As a structural marker released from epithelial cells undergoing apoptosis or necrosis, cystatin B is particularly valuable for the early detection of AKI, especially during the initial phases if conventional functional biomarkers, such as serum CRE or SDMA, may remain within reference intervals (23). The gene discussed is CSTB; the disease is acute kidney injury.